ANKRD20A1 and breast cancer: There is currently little evidence in the literature describing checkpoint kinase 2 pseudogene 2 (CHEK2P2) at 15q11.1, Myosin Heavy Chain 1 (MYH1) at 17p13.1 or Ankryn Repeat Domain 20 Family Member A1 (ANKRD20A1) at 9q21.11 as significant genes in BC.